ALL N = 50 | |
---|---|
Age (years), median (IQR) | 71.50 (56.75; 79.25) |
Gender, male n (%) | 30 (60.0) |
Dialysis vintage (months), median (IQR) | 47.0 (26.5; 110.5) |
Diabetes, n (%) | 18 (36.0) |
Hypertension, n (%) | 38 (76.0) |
Smoking, n (%) | 8 (16.0) |
Calcification score, median (IQR) | 7.0 (2.0; 13.25) |
Baseline dp-ucMGP (pM), median (IQR) | 3179.15 (1825.25; 4339.50) |
NCBB, n (%) | 20 (40.0) |
Residual diuresis, n (%) | 6 (12.0) |
Calcium dose (tablets of 600 mg), median (IQR) | 1.00 (1.00; 2.25) |
Alfacalcidol dose (μg), median (IQR) | 0.75 (0.00; 1.50) |
Serum phosphate (mg/dl), median (IQR) | 3.90 (3.17; 4.65) |
Serum calcium (mg/dl), median (IQR) | 9.10 (8.80; 9.30) |
PTH (pg/ml), median (IQR) | 188.50 (117.75; 266.50) |
LDL cholesterol (mg/dl), median (IQR) | 92.0 (77.0; 113.0) |
BMI (Kg/m2), median (IQR) | 25.82 (22.85; 28.42) |
URR, median (IQR) | 75.0 (71.0; 79.0) |
Albumin (g/l), median (IQR) | 39.0 (36.0; 41.0) |
CAD, n (%) | 14 (28.0) |
Cinacalcet, n (%) | 2 (4.0) |
Previous acenocoumadin, n (%) | 6 (12.0) |
PTHX, n (%) | 2 (4.0) |
Recent fracture, n (%) | 3 (6.0) |